Navitoclax

Overview

Navitoclax is an orally active, synthetic small molecule and an antagonist of a subset of the B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | Bcl-2 Family

Product Information

• Catalog No.: B0084-100624
• CAS No.: 923564-51-6
• Molecular Formula: C47H55ClF3N5O6S3
• Molecular Weight: 974.611
• Purity: 98%

Source

Original product source